A detailed history of Stifel Financial Corp transactions in Abb Vie Inc. stock. As of the latest transaction made, Stifel Financial Corp holds 2,455,969 shares of ABBV stock, worth $421 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares
2,455,969
Previous 2,312,952 6.18%
Holding current value
$421 Million
Previous $358 Million 24.77%
% of portfolio
0.52%
Previous 0.46%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$159.82 - $182.1 $22.9 Million - $26 Million
143,017 Added 6.18%
2,455,969 $447 Million
Q4 2023

Feb 12, 2024

SELL
$137.6 - $154.97 $5.02 Million - $5.65 Million
-36,468 Reduced 1.55%
2,312,952 $358 Million
Q3 2023

Nov 13, 2023

SELL
$133.59 - $154.65 $1.03 Million - $1.19 Million
-7,677 Reduced 0.33%
2,349,420 $350 Million
Q2 2023

Aug 14, 2023

SELL
$132.51 - $164.9 $30.8 Million - $38.3 Million
-232,261 Reduced 8.97%
2,357,097 $318 Million
Q1 2023

May 12, 2023

SELL
$144.61 - $166.54 $36 Million - $41.4 Million
-248,671 Reduced 8.76%
2,589,358 $413 Million
Q4 2022

Feb 13, 2023

BUY
$138.31 - $165.87 $3.06 Million - $3.67 Million
22,100 Added 0.78%
2,838,029 $459 Million
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $11.2 Million - $12.8 Million
83,447 Added 3.05%
2,815,929 $378 Million
Q2 2022

Aug 15, 2022

SELL
$137.62 - $174.96 $7.89 Million - $10 Million
-57,361 Reduced 2.06%
2,732,482 $419 Million
Q1 2022

May 13, 2022

SELL
$131.98 - $163.75 $655,280 - $813,018
-4,965 Reduced 0.18%
2,789,843 $452 Million
Q4 2021

Feb 14, 2022

BUY
$107.43 - $135.93 $9.89 Million - $12.5 Million
92,082 Added 3.41%
2,794,808 $378 Million
Q3 2021

Nov 15, 2021

BUY
$106.4 - $120.78 $9.34 Million - $10.6 Million
87,752 Added 3.36%
2,702,726 $292 Million
Q2 2021

Aug 13, 2021

BUY
$105.21 - $117.21 $7.56 Million - $8.42 Million
71,832 Added 2.82%
2,614,974 $295 Million
Q1 2021

May 14, 2021

BUY
$102.3 - $112.62 $30.9 Million - $34 Million
301,638 Added 13.46%
2,543,142 $275 Million
Q4 2020

Feb 12, 2021

BUY
$80.49 - $108.67 $873,396 - $1.18 Million
10,851 Added 0.49%
2,241,504 $240 Million
Q3 2020

Nov 16, 2020

BUY
$85.91 - $100.83 $3.46 Million - $4.06 Million
40,299 Added 1.84%
2,230,653 $195 Million
Q2 2020

Aug 14, 2020

BUY
$73.37 - $98.18 $9.77 Million - $13.1 Million
133,135 Added 6.47%
2,190,354 $215 Million
Q1 2020

May 14, 2020

SELL
$64.5 - $97.79 $14.3 Million - $21.7 Million
-221,990 Reduced 9.74%
2,057,219 $157 Million
Q4 2019

Feb 13, 2020

BUY
$72.13 - $90.25 $9.44 Million - $11.8 Million
130,911 Added 6.09%
2,279,209 $202 Million
Q3 2019

Nov 19, 2019

BUY
$62.98 - $75.72 $2.05 Million - $2.46 Million
32,483 Added 1.54%
2,148,298 $163 Million
Q3 2019

Nov 13, 2019

SELL
$62.98 - $75.72 $17 Million - $20.5 Million
-270,608 Reduced 11.34%
2,115,815 $160 Million
Q2 2019

Aug 14, 2019

BUY
$65.7 - $83.98 $9.06 Million - $11.6 Million
137,955 Added 6.14%
2,386,423 $174 Million
Q1 2019

May 14, 2019

BUY
$77.14 - $90.79 $5.52 Million - $6.49 Million
71,527 Added 3.29%
2,248,468 $181 Million
Q4 2018

Feb 13, 2019

BUY
$77.85 - $96.01 $4.21 Million - $5.2 Million
54,132 Added 2.55%
2,176,941 $201 Million
Q3 2018

Nov 13, 2018

BUY
$88.91 - $98.84 $7.9 Million - $8.79 Million
88,901 Added 4.37%
2,122,809 $201 Million
Q2 2018

Aug 14, 2018

BUY
$89.78 - $106.23 $4.12 Million - $4.88 Million
45,891 Added 2.31%
2,033,908 $189 Million
Q1 2018

May 11, 2018

SELL
$92.01 - $123.21 $14.2 Million - $19.1 Million
-154,733 Reduced 7.22%
1,988,017 $188 Million
Q4 2017

Feb 14, 2018

SELL
$89.56 - $98.21 $16.4 Million - $18 Million
-183,192 Reduced 7.88%
2,142,750 $207 Million
Q3 2017

Nov 13, 2017

BUY
$69.85 - $89.22 $162 Million - $208 Million
2,325,942
2,325,942 $0

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $303B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Stifel Financial Corp Portfolio

Follow Stifel Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.